Yasuda, Hisataka <br/><br/>
Anti-RANKL antibody was approved for the treatment of osteoporosis in Japan.  [electronic resource] 

 -  Nihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology  2013 
 - 209-16 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1349-7413 
<br/><br/><label>Standard No.: </label>10.2177/jsci.36.209  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antibodies, Monoclonal, Humanized--therapeutic use<br/>Denosumab<br/>Humans<br/>Osteoclasts--drug effects<br/>Osteoporosis--drug therapy<br/>RANK Ligand--immunology